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Introduction
Paediatric respiratory medicine is recognised as an important separate track at the European Respiratory
Society (ERS) International Congress. In this article, the Group Chairs of the ERS Paediatric Assembly
highlight some of the most interesting abstracts in infection, intensive care, bronchology, cystic fibrosis
(CF), physiology, sleep medicine and asthma that were presented at the 2016 ERS International Congress.
Infection
Over recent years the widely held belief that the lower airways were in some way uniquely sterile has been
overturned with a general recognition that there is a resident microbiota which appears to be largely derived
from the oropharynx. We have only a rudimentary understanding of the dynamics of these microbial
populations but it is now recognised that the populations may change significantly during acute and chronic
pulmonary disease. Data from the UK on the composition of the bacterial community in the airways of
healthy children were presented. Samples were obtained using “blind” bronchial brushings, and compared
with those present in the airways of children with recurrent or persistent bacterial bronchitis (PBB)
undergoing bronchoscopy [1]. Data were generated using 16s RNA sequencing. Paired “blind” brushings and
bronchoscopically guided brushings were obtained from the symptomatic children, with the results generated
using “blind” brushings obtained via endotracheal tubes reflecting those obtained bronchoscopically,
suggesting this is a valid approach to study lower airways microbial populations. As might be predicted, the
density of bacteria in the symptomatic children did not differ significantly from that in the healthy children
but the diversity was significantly reduced, possibly reflecting the formation of biofilms that permit the usual
suspects to come to dominate this particular ecological niche (figure 1). The chronic neutrophilic
inflammatory response characteristic of PBB is thought to result in airways damage and eventually the
formation of bronchiectasis if it is not cleared by the host or is not treated effectively. Unsurprisingly, loss of
diversity within the bacterial community contained in sputum from HIV-infected children with established
bronchiectasis was the principle finding from a study undertaken in South Africa [2]. In this case, the
control group were children with CF from previous studies who might be expected to manifest a loss of
diversity when compared with healthy individuals, highlighting the magnitude of the changes in the HIV
bronchiectasis group. The clinical importance of PBB was presented by GRAMMENIATIS et al. [3], who found
that 40 (56.3%) out of 71 children with PBB were symptom free for 12 months after treatment of varying
duration (20.2±7.7 months) with a mean delay in diagnosis of 18.5±15.9 months. In parallel with the
advances being made in our understanding of microbial communities within the airways and gut as a player
in health and disease, new “omics” technology in the form of either metabolomics or phenomics is starting
to play an increasing role in research and indeed in clinical practice. Systems biology, integrating many of
the novel technologies as well as traditional approaches, is likely to move into the mainstream in coming
years. A presentation from a Taiwanese group of researchers presented data suggesting that 1H-nuclear
magnetic resonance spectroscopy, which is used to characterise the metabolomic profile of pleural fluid, is
able to predict those in whom more aggressive intervention might be required [4]. The exact role
metabolomics may play in diagnosis and monitoring in the future is yet to be determined.
Acute bronchiolitis continues to be one of the commonest causes for hospitalisation in infants and young
children. Treatment has changed little over the past 50 years with good supportive care being key to
management. A study addressing the potential role of high-flow oxygen as a means of improving
supportive care undertaken in Newcastle, Australia, was presented with the authors concluding that the
approach may offer significant benefits in terms of reducing the number of children reaching intensive
care but had no impact on duration of oxygen therapy [5]. A theoretical health economic study suggested
that this approach may be cost effective by reducing the costs associated with intensive care [6]. However,
the latter group noted that there have not been large definitive prospective randomised clinical trials to
support this position. The same group reported that only 0.25% of infants admitted with acute
bronchiolitis required intensive care [7], while another group in a unit not using high flow as a form of
respiratory support found 14% required “high dependency” nursing but made no comment regarding
intensive care usage [8]. A recent study retrospectively assessing a small number of “controls” suggested as
many as 33% of infants might be admitted to paediatric intensive care and such discrepancies in local
practice make assessment of small scale studies difficult [9]. A presentation assessing the impact of
respiratory syncytial virus (RSV) monoclonal antibody levels in vitro concluded that re-activation of
abortive RSV replication might occur spontaneously when antibody levels fall [10].
A Brazilian group reported outcomes in 21 children who developed necrotising pneumonia [11], a
condition that appears to be becoming more common. Prolonged antibiotic therapy combined with
drainage of the associated empyema present in the 81% of subjects with this finding resulted in an
“excellent” outcome for all of the patients. Findings were consistent with previous reports. Differentiated
nasal epithelial cells were used to explore potential differences in the inflammatory response of the airways
epithelium in those with atopic asthma, non-atopic asthma and non-atopic controls in a study undertaken
https://doi.org/10.1183/23120541.00127-2016 2
PAEDIATRICS | J. GRIGG ET AL.
in Scotland, UK [12]. The authors concluded that there are some aspects of the response in “asthmatic”
epithelium (albeit from the nose) that is different from that attributable to “atopy”. The difficulty with
these studies of course is trying to untangle what might be innate and what may be secondary to the
particular condition, particularly given the increasing knowledge around epigenetic changes.
Intensive care
Respiratory management of infants and young children has been an important area of research over the
previous year. Hence, the 2016 ERS Congress addressed the important area of the very early physiological
pulmonary adaptation to prevent infantile lung disease [13, 14], and the long-term outcomes of neonatal
lung disease. HARRIS et al. [15] investigated the first breath during neonatal resuscitation with regards to
applied inflation pressures and to characterise the factors associated with a shorter time to the first active
inspiration in 47 infants aged <34 weeks gestation requiring resuscitation at birth. The authors found that
the median time to the first active inflation was inversely correlated with the applied peak pressure
(p=0.001) and inflation time (p=0.018) of the first active inflations. These observations support the
concern that during preterm resuscitation too low an initial inflation pressure may delay pulmonary
transition and indeed high initial pressures may be beneficial when supporting fetal-to-neonatal transition.
Also investigating the initial respiratory support, KAMLIN et al. [16] examined optimising neonatal
resuscitation in the delivery room by use of an Guedel oropharyngeal airway (OPA) in infants aged
<34 weeks gestation. The assumption was that use of an OPA reduces airway obstruction, facilitates
improved ventilation and improves clinical outcomes. Infants were studied in a two centre randomised
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FIGURE 1 The pulmonary microbiome of children with persistent bacterial bronchitis (PBB). DNA was extracted from bronchial brushes of 24 PBB
children and 18 healthy controls and 16S rRNA gene qPCR quantified the bacterial burden prior to sequencing. Permutational multivariate
analysis of variance shows that total community dissimilarity is significantly different (R2=0.08, p=0.004) and indicator species analysis shows that
Haemophilus is significantly associated with PBB. Reproduced from [1] with permission from the publisher.
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controlled trial (RCT) and, following randomisation, managed using standard national guidelines and
randomised to face mask (control) or mask plus OPA (intervention) positive pressure ventilation (PPV)
provided by a T-piece resuscitator. Using a physiological data acquisition set to measure the incidence of
complete (no gas flow) and partial airway obstruction, the authors reported that face mask obstruction was
common during PPV and use of OPAs was associated with significantly higher rates of partial obstruction
[16]. Working in the same environment (i.e. the delivery room), PAHUJA et al. [17] studied expiratory tidal
volume (VT) and end-tidal carbon dioxide tension (PETCO2) during resuscitation of prematurely born
infants. The hypothesis was that prematurely born infants who developed intracranial haemorrhages or
bronchopulmonary dysplasia (BPD) were given higher expiratory VT (>6 mL·kg−1) and/or had low PETCO2
levels during resuscitation and stabilisation in the delivery room. Again, infants with a gestational age of
<34 weeks were studied around the time of birth. Expiratory VT and PETCO2 levels were simultaneously
recorded using a respiratory function monitor. Of the 80 infants studied, 36 developed intracranial
haemorrhages and 34 developed BPD. The authors found a greater number of inflations at birth with a
high expiratory VT (p 0.001) and a low PETCO2 (p 0.01) in the intracranial haemorrhage-affected infants,
stressing the well-established point that hypocarbia is a significant risk factor for intracranial
haemorrhages in neonates. Furthermore, their results emphasise how the use of a respiratory function
monitor can be helpful in gauging resuscitative efforts during neonatal resuscitation and improve
outcomes of prematurely born infants [18].
In the neonatal unit, continuous positive airway pressure (CPAP) and appropriately conditioned breathing
gasses are the commonest method of choice for noninvasive respiratory support [19, 20]. However, while
clinical studies in adults suggest that mouth leaks impair gas conditioning during CPAP, similar data for
neonates is lacking. In a bench top study, FISCHER et al. [19] studied the impact of mouth leaks on
oropharyngeal temperature and humidity during neonatal CPAP. The authors found that during CPAP,
mouth leaks impaired oropharyngeal gas conditioning significantly, but heated humidification maintained
clinically acceptable humidity levels. The topic of ongoing respiratory support after initial stabilisation is a
matter of continuing debate. High-flow nasal cannula therapy has recently been proposed as an alternative
to nasal CPAP [20, 21]. In their presentation, MAZMANYAN et al. [22] investigated the influence of nasal
high-flow therapy via nasal cannula on the minute ventilation of newborn infants compared to controls
(no respiratory support). Using respiratory inductance plethysmography, 17 newborn infants were
monitored during 8 L·min−1 of high-flow nasal cannula therapy. Results were remarkable in as much as
their ventilatory response during nasal high-flow therapy resulted in a significant reduction in minute
ventilation (0.664±0.207 to 0.506±0.145 L·min−1; p=0.0006), an effect previously only described in adult
studies of nasal high-flow therapy. The trend for increased use of nasal high-flow therapy was reported in
three posters presented at the Congress [23–25], with nasal high-flow therapy in neonates in UK neonatal
intensive care units increasing from 56% in 2012 to ∼90% in 2015. Studies were also presented on refining
invasive ventilation and use of advanced ventilator technology and software to optimise ventilator
management. In an interesting study, BENTSEN et al. [26] investigated whether using flow data from a
mechanical ventilator would be helpful in predicting the development of BPD in extremely preterm
neonates. In this study, investigators aimed to investigate whether simple lung mechanics, obtained from
flow data from a mechanical ventilator, could be used to predict BPD in extremely preterm infants. In 21
preterm neonates with a mean gestational age of 25.9 weeks, data from the first days of ventilation were
gathered and analysed by specific software with respect to the flow at 50% exhaled volume as ratio of peak
flow (F50) and the results correlated to the clinical outcome of BPD severity. Values for F50 were
significantly higher in the moderate/severe BPD group, compared to no or mild BPD: 68.0 versus 84.4
(p=0.011). The study therefore suggests that data obtained from ventilators during early hours of life may
help to predict later BPD in preterm neonates.
A number of contributions to the 2016 ERS Congress were related to the long-term outcome of BPD.
Following up outcomes of preterm infants, HARRIS et al. [15] studied the impact of post-natal corticosteroids
treatment of very premature infants on their lung function testing at school age. In a cohort of 244
ex-preterm, very low birth weight infants at 11–14 years of age, these researchers found that the subgroup of
infants with BPD who had been exposed to post-natal corticosteroids had significantly reduced lung
function values in their expired vital capacity (forced expiratory flow at 25%, 50% and 75% of forced vital
capacity (FEF25, FEF50, FEF75), respectively), forced expiratory volume in 1 s (FEV1) and peak expiratory
flow compared with unexposed infants with BPD. These results suggest that post-natal corticosteroids,
administered to the sickest infants at the time of mechanical ventilation, may have long-term adverse effects
on lung function. A late-breaking abstract by MOSCHINO et al. [27], prospectively followed neonatal patients
with BPD from infancy to adulthood. Data from the patient cohort first studied in 1991 and followed up
until early 2016 was analysed to longitudinally investigate the evolution of lung function in neonatal
intensive care unit survivors with BPD. A total of 17 patients with a birth weight <1250 g who had
moderate-to-severe BPD were subjected to regular lung function studies, including maximal flow at
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functional residual capacity at 2 years and FEV1, forced vital capacity and FEF25–75 at ages 9, 15, 20 and
24 years. Results confirmed the concept of “tracking” of lung function with consistent lung function tracking
between 2 and 24 years of age in survivors of BPD [28]. Mean z-scores for forced vital capacity and FEF25–75
did not change significantly between different ages (p>0.5 and p=0.45, respectively). Significant correlations
were found between the z-scores for maximal flow at functional residual capacity at 2 years and for FEV1 at
ages 15 years (r=0.74, p=0.001), 20 years (r=0.75, p<0.001) and 24 years (r=0.69, p=0.003). At 24 years, a
positive bronchodilator response was observed in almost a quarter (23.5%) of subjects [28]. The importance
of early respiratory support and its long-term consequences were highlighted in a keynote lecture by
Dr Roehr who, in a presentation in the Paediatric Year in Review session, reflected on the origins of
noninvasive respiratory support of neonates and presented the most recent trials of using noninvasive
respiratory support in infants and young children. Acknowledging that nasal CPAP remains the gold
standard of noninvasive respiratory support in neonatal and paediatric intensive care units, the physiology of
high-flow nasal cannula was reviewed and recent trials on the application of nasal high-flow therapy
throughout the delivery room, neonatal and paediatric intensive care units were discussed.
Bronchoscopy
Results of a survey of the use of bronchoscopy, performed in collaboration with the national
representatives of 44 European countries, was reported during the Congress. The most frequent indication
for diagnosis was chronic cough and stridor and, for acute use, foreign body aspiration [29]. By contrast,
European expertise in bronchoscopic stenting of the narrowed bronchus is uncommon. Indeed, SERIO et al.
[30], showed that bronchoscopic stenting is not straightforward. In seven children aged 0–13 years with
left mainstem bronchus obstruction treated with expandable metallic balloon all children had major
complications after a median (range) of 2.5 (0.25–5) years.
Cystic fibrosis
The expanding adult CF population reflects the major improvements in the clinical care of children and
young people with CF. This has led to an urgent need for the development of more adult centres, which
must be combined with training more physicians and members of the multidisciplinary team to look after
these complex patients. In 2015 the joint European Respiratory Society/European CF Society task force
reported their recommendations for the future care of adults with CF [31]. The biggest hurdle will be the
financial implications for healthcare services. Meanwhile, CF research is undoubtedly contributing to
improvements in life expectancy. Use of the lung clearance index (LCI), which measures ventilation
inhomogeneity, is becoming more common in CF clinics as it has been shown to be a useful marker of CF
lung disease; it is also one of the more sensitive outcome measures available for clinical trials. Since
longitudinal data are needed, a group presented a 5-year study of 80 stable Greek patients and found the
mean annual change in LCI was 5% compared to 0.01% for FEV1 [32]. However, the change in LCI was
not predicted by age, Pseudomonas status, or initial LCI and FEV1. Therefore, the clinical utility of
measuring LCI at annual review remains to be seen. A larger study from North America followed 76 CF
preschool children (aged 2.5–6 years) and 71 healthy controls measuring LCI six times over 1 year [33].
The researchers found that LCI was significantly worse in patients with a pulmonary exacerbation (mean
0.6 rise), whereas in healthy children it did not change with episodes of upper respiratory symptoms. With
newborn screening we have become more aware of patients with CF-screen positive inconclusive diagnosis,
CF patients with a borderline sweat test in the presence of none or one CFTR (CF transmembrane
conductance regulator) gene mutation, or with a normal sweat test in the presence of two CFTR gene
mutations; one of which has uncertain significance. Their clinical course is almost always milder than
“classic CF” and this has been confirmed in a small Italian study where LCI in 17 children in this category
were compared to 37 CF patients and nine healthy controls; mean LCI was lower (i.e. better) than the CF
patients (7.2 versus 9.7) and nonsignificantly higher than the controls [34]. It would be useful if a
pulmonary exacerbation could be predicted, or at least detected early. Addressing this, a Dutch study
assessed electronic home monitoring. 49 children were asked to use an electronic monitor (measuring
FEV1 and a respiratory symptom questionnaire) three times a week [35]. Data were only analysable from
37 children, 28 of whom had at least one pulmonary exacerbation. The combined data were predictive of
an exacerbation (93% sensitivity and 89% specificity), but given the cost, issues of adherence and staff time
for monitoring the data, it remains unclear whether this technology has any advantage from the usual
process of parents contacting their CF team when their child has symptoms. A group from Israel studied
the use of spirometry inspiratory capacity in 98 patients [36]. They found that once the inspiratory
capacity reached <60% predicted there was an accelerated decline in inspiratory capacity, accompanying a
rise in residual volume (whilst total lung capacity remained in the normal range). The decline in
inspiratory capacity did not correlate with a fall in FEV1 and the researchers suggested that their data:
1) indicated that air trapping may account for increasing breathlessness, and 2) that this measure added
useful information to the usual parameters assessed by spirometry. Magnetic resonance imaging scanning
https://doi.org/10.1183/23120541.00127-2016 5
PAEDIATRICS | J. GRIGG ET AL.
is being studied to see whether it could replace computed tomography scanning with its inherent radiation
burden. In a small Swiss–UK study of oxygen-enhanced magnetic resonance, it was found that functional
lung imaging has the capability of assessing severity of lung disease, correlating with FEV1 and the
computed tomography Brody score [37]. The images presented were stunning, but given the complexity,
availability and cost it is unlikely to be a widely used clinical tool in the near future. Exercise is
encouraged for all patients with CF but its uptake by children is highly variable, probably reflecting the
sedentary lifestyle led by many healthy children. A UK study randomised 71 children into a control group
receiving usual specialist CF care or an intervention group who also received weekly supervised exercise
for 2 years [38]. No difference was seen in lung function (FEV1, LCI or peak oxygen uptake); however, the
intervention group were fitter, with a significant difference in improvement seen in 10-min modified
shuttle walking test. Given the burden of the intervention this is disappointing, but does not mean we
should stop encouraging exercise. How many of the children continue to exercise long term once the
supervision stops remains to be seen.
Epidemiology
Epidemiological data on primary ciliary dyskinesia (PCD), epigenetics and asthma were presented. The
diagnosis of PCD needs standardisation, and easy and simple diagnostic tools are still required. The same
group that recently published a validated symptom score (PICADAR) [39], presented a study showing that
nasal nitric oxide to PICADAR had a high sensitivity and negative predictive value of 100% when used as
a diagnostic tool [40]. As a novel diagnostic method, immunofluorescence labelling of ciliary proteins
provides results within 48 h, which is substantially faster than transmission electron microscopy. A study
on immunofluorescence showed immunofluorescence as 57% sensitive and 100% specific compared to
“gold standard” transmission electron microscopy [41]. The role of pre- and post-natal factors on
respiratory health across the life course was an important theme. First, data from the Swedish National
Registry, showed that maternal grandmother’s smoking status is associated with an increased risk of early
persistent asthma (OR 1.38, 95% CI 1.15–1.65) [42]. Second, data were presented showing that reduced
first and second trimester fetal size is associated with increased risk for asthma up to 10 years of age. Each
z-score increase in first trimester size was associated with reduced risk for asthma at ages 5, 10 and 15
years [43]. Third, in a population-based birth cohort, maternal intake of sugar was positively associated
with wheeze, total IgE and atopic asthma [44]. Finally, in a study analysing nine prospective European
birth cohorts, elective caesarean section was associated with an increased risk of asthma [45]. The causal
underlying mechanisms for these associations require further research. Predictors of future asthma in
school age and adulthood continue to be of interest to researchers. One possibility is that multiple trigger
wheeze (i.e. wheeze with and between viral colds) in preschool children identifies a group at increased risk
of school age asthma. According to the data obtained from a longitudinal birth cohort study, children with
severe wheeze and multiple trigger wheeze at preschool age had the greatest risk of doctor-diagnosed
asthma at 8 years of age [46]. At each level of severity, multiple trigger wheeze potentiated the risk of
asthma compared to having episodic viral wheeze [46]. In a study on the data from the Isle of Wight Birth
Cohort, children still wheezing at 18 years were more likely to be atopic, female, diagnosed as asthmatic at
10 years of age, and have higher levels of bronchial hyperreactivity at 10 years of age [47]. The Perth
Infant Asthma follow-up study showed lung function from soon after birth was predictive of the FEV1/
forced vital capacity ratio in young adults, suggesting that chronic obstructive pulmonary disease may have
origins in the antenatal developing lung. Breastfeeding was protective against reduced FEV1/forced vital
capacity and should continue to be promoted [48].
Physiology and sleep
Spirometry, static lung volumes, gas transfer measurements and polysomnography (PSG) remain the
mainstay of respiratory and sleep medicine. However, there is a quiet revolution of both old and newer
tests emerging into clinical practice. Nowhere is this more evident than in rare diseases, a field in which
we are constantly challenged to deliver better answers. The research presented at the 2016 ERS Congress
demonstrates that we continue to ask which test. Duchenne muscular dystrophy affects one in 3500 boys,
is incurable and leads to early mortality in the late 20 s as a result of respiratory failure. Disease modifying
treatments are only just emerging and therefore management remains supportive. Nocturnal
hypoventilation represents a critical turning point in the progression of Duchenne muscular dystrophy
and, although PSG testing remains the gold standard for its identification, overnight oximetry is
recommended as a screening test by the British Thoracic Society [49]. BAKER et al. [50] compared
overnight oximetry and transcutaneous oxicapnography as a sensitive screening tool. They demonstrated
that oximetry alone was insensitive to elevated carbon dioxide and that the use of the combination of
oxygen and carbon dioxide monitoring conferred the highest sensitivity to nocturnal hypoventilation.
Further work is needed to replicate these findings and to compare against full PSG outcomes, but if
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confirmed would offer low-cost, home-based opportunities to improve the screening of patients with
Duchenne muscular dystrophy.
The impact of PCD on lung function and the natural history of disease progression on lung function
outcomes are not well understood, hampering our ability to manage disease progression. HALBEISEN et al.
[51] collated over 1400 spirometry results from 276 children and young people with PCD from the iPCD
cohort. Spirometry outcomes in individuals with PCD were lower than the norm as derived from the
Global Lung Function Initiative and significantly declined over time with FEV1 decreasing by −0.07
z-scores per year and, while this represents a relatively modest function, impact would lead to clinically
relevant reductions (>0.5 z-score) over childhood. Clearly, the challenge of identifying clinical
characteristics associated with accelerated decline and therefore potentially actionable management targets
remain. In contrast to CF lung disease, LCI does not appear to be sensitive to PCD lung disease [52] and
until the question of which test proves the most clinical useful information is resolved, spirometry
continues to be the gold standard.
The prognosis for infants born with congenital diaphragmatic hernia have dramatically improved over the
past 60–70 years such that survival has now been reported to be as high as 90% in some centres [53]. This
increased survival is often at the cost of significant and persistent respiratory morbidity. ROHDIN et al. [54]
reported the novel application of single positron emission computed tomography imaging to assess
ventilation perfusion in 23 infants with congenital diaphragmatic hernia in the first year of life. Not
surprisingly, ventilation/perfusion varied widely amongst infants and was most affected in infants
requiring patch surgery and/or extracorporeal membrane oxygenation. However, ventilation/perfusion
function did not match the clinical course in all cases with some infants highlighting the potential benefits
for this form of functional assessment to assist in the long-term management of individual with congenital
diaphragmatic hernia.
Asthma mechanisms
Although asthma is highly prevalent and has been extensively studied, novel methodologies are needed to
determine the exact role of inflammation and remodelling in this complex clinical/pathological entity [55].
At the 2016 Congress there was a significant emphasis on the role of prenatal period factors on asthma
development. Starting with the amniotic fluid, a Dutch–Italian group analysed the amniotic fluid of 142
infants at birth by the untargeted approach of metabolomics (mass spectrometry and liquid
chromatography) and was able to retrospectively discriminate infants who developed recurrent wheezing
during the first year of life from those who did not develop wheezing. The results suggested early oxidative
stress and impaired methylation as prenatal pathogenic mechanisms of recurrent wheezing [56]. An
Australian study assessed the effect of prenatal hypoxia-induced growth restriction on lung structure in adult
rats [57]. Based on the observation in humans that intra-uterine growth restriction is associated with asthma
in childhood and adulthood and the assumption that this growth restriction is due to fetal hypoxia, the
researchers temporarily housed pregnant Sprague Dawley rats under hypoxic conditions (11.5% oxygen).
These hypoxic conditions were in the phase that the airways develop, the pseudoglandular-canicular phase
from gestational days 13–20, rats were then returned to normoxia until the end of gestation at days 21–23.
The rats indeed had lower weight at birth, but the weight difference disappeared by 7 weeks. In utero growth
restriction unexpectedly had no impact on mean airway measurements or lung structure, but there was a
more heterogeneous distribution of airway lumen calibre and an increased number of lung macrophages.
Whether these changes reflect a pro- or anti-inflammatory milieu remains to be established. Moving to
post-natal factors, a retrospective review of 109 children with severe therapy-resistant asthma who underwent
bronchoscopies for evaluation of their asthma found that 20% had a positive bronchoalveolar lavage bacterial
culture. A positive culture was associated with a higher maintenance dose of inhaled steroid, lower FEV1 and
higher bronchoalveolar lavage neutrophils [58]. Thus, children with severe therapy resistant asthma and
bacterial infection or colonisation seem to have more severe disease.
Inhaled pollutants
The role of the environment in the development of asthma has long been recognised. In a RCT of 150
children with persistent asthma, led by a nursing group from Baltimore (MD, USA), the IgE levels to
mouse and cockroach were measured and related to neighbourhoods with the highest quartile of reported
dirty alleys/streets compared to other neighbourhoods [59]. Furthermore, mean perceived neighbourhood
stress scores were related to dirty alley neighbourhood status. Higher IgE to mouse (59% versus 42%), but
not cockroach allergen (46% versus 40%), was significantly associated with living in a dirty
neighbourhood. An emerging topic that was extensively covered during the Congress was use of
e-cigarettes. The sale of e-cigarettes is increasing exponentially and e-cigarettes draw on themes of the
defunct advertising of conventional cigarettes. Perhaps this would not be of concern if e-cigarettes were a
highly effective non-toxic way of encouraging conventional cigarette smokers to stop. However, whether
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substantial persistent reduction in cigarettes smoked is achieved in dual smokers remains unclear since
significant conflict of interests occur in over one-third of published studies, and to date no overall
conclusion on the safety of e-cigarettes can be drawn [60, 61].
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